Year |
Citation |
Score |
2021 |
Lee YH, Lee HJ, Kim HC, Lee Y, Nam SK, Hupperetz C, Ma JS, Wang X, Singer O, Kim WS, Kim SJ, Koh Y, Jung I, Kim CH. PD-1 and TIGIT downregulation distinctly affect the effector and early memory phenotypes of CD19-targeting CAR T cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 34628052 DOI: 10.1016/j.ymthe.2021.10.004 |
0.471 |
|
2021 |
Lee SC, Ma JSY, Kim MS, Laborda E, Choi SH, Hampton EN, Yun H, Nunez V, Muldong MT, Wu CN, Ma W, Kulidjian AA, Kane CJ, Klyushnichenko V, Woods AK, et al. A PSMA-targeted bispecific antibody for prostate cancer driven by a small-molecule targeting ligand. Science Advances. 7. PMID 34380625 DOI: 10.1126/sciadv.abi8193 |
0.753 |
|
2021 |
Ma J, Tran G, Wan AMD, Young EWK, Kumacheva E, Iscove NN, Zandstra PW. Microdroplet-based one-step RT-PCR for ultrahigh throughput single-cell multiplex gene expression analysis and rare cell detection. Scientific Reports. 11: 6777. PMID 33762663 DOI: 10.1038/s41598-021-86087-4 |
0.354 |
|
2018 |
Viaud S, Ma JSY, Hardy IR, Hampton EN, Benish B, Sherwood L, Nunez V, Ackerman CJ, Khialeeva E, Weglarz M, Lee SC, Woods AK, Young TS. Switchable control over in vivo CAR T expansion, B cell depletion, and induction of memory. Proceedings of the National Academy of Sciences of the United States of America. PMID 30373813 DOI: 10.1073/Pnas.1810060115 |
0.8 |
|
2018 |
Laird JH, Lok BH, Ma J, Bell A, de Stanchina E, Poirier JT, Rudin CM. Talazoparib is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and Xenografts. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29945991 DOI: 10.1158/1078-0432.Ccr-18-0401 |
0.303 |
|
2017 |
Wang W, Fujii H, Kim HJ, Hermans K, Usenko T, Xie S, Luo ZJ, Ma J, Celso CL, Dick JE, Schroeder T, Krueger J, Wall D, Egeler RM, Zandstra PW. Enhanced human hematopoietic stem and progenitor cell engraftment by blocking donor T cell-mediated TNFα signaling. Science Translational Medicine. 9. PMID 29263228 DOI: 10.1126/Scitranslmed.Aag3214 |
0.388 |
|
2016 |
Cao Y, Rodgers DT, Du J, Ahmad I, Hampton EN, Ma JS, Mazagova M, Choi SH, Yun HY, Xiao H, Yang P, Luo X, Lim RK, Pugh HM, Wang F, et al. Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer. Angewandte Chemie (International Ed. in English). 55: 7520-4. PMID 27145250 DOI: 10.1002/Anie.201601902 |
0.717 |
|
2016 |
Wang Y, Li Y, Thérien-Aubin H, Ma J, Zandstra PW, Kumacheva E. Two-dimensional arrays of cell-laden polymer hydrogel modules. Biomicrofluidics. 10: 014110. PMID 26858822 DOI: 10.1063/1.4940430 |
0.444 |
|
2016 |
Rodgers DT, Mazagova M, Hampton EN, Cao Y, Ramadoss NS, Hardy IR, Schulman A, Du J, Wang F, Singer O, Ma J, Nunez V, Shen J, Woods AK, Wright TM, et al. Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies. Proceedings of the National Academy of Sciences of the United States of America. 113: E459-68. PMID 26759369 DOI: 10.1073/Pnas.1524155113 |
0.645 |
|
2016 |
Ma JS, Kim JY, Kazane SA, Choi SH, Yun HY, Kim MS, Rodgers DT, Pugh HM, Singer O, Sun SB, Fonslow BR, Kochenderfer JN, Wright TM, Schultz PG, Young TS, et al. Versatile strategy for controlling the specificity and activity of engineered T cells. Proceedings of the National Academy of Sciences of the United States of America. 113: E450-8. PMID 26759368 DOI: 10.1073/Pnas.1524193113 |
0.811 |
|
2015 |
Cao Y, Axup JY, Ma JS, Wang RE, Choi S, Tardif V, Lim RK, Pugh HM, Lawson BR, Welzel G, Kazane SA, Sun Y, Tian F, Srinagesh S, Javahishvili T, et al. Multiformat T-cell-engaging bispecific antibodies targeting human breast cancers. Angewandte Chemie (International Ed. in English). 54: 7022-7. PMID 25919418 DOI: 10.1002/Anie.201500799 |
0.67 |
|
2015 |
Kim MS, Ma JS, Yun H, Cao Y, Kim JY, Chi V, Wang D, Woods A, Sherwood L, Caballero D, Gonzalez J, Schultz PG, Young TS, Kim CH. Redirection of genetically engineered CAR-T cells using bifunctional small molecules. Journal of the American Chemical Society. 137: 2832-5. PMID 25692571 DOI: 10.1021/Jacs.5B00106 |
0.844 |
|
2014 |
Kularatne SA, Deshmukh V, Ma J, Tardif V, Lim RK, Pugh HM, Sun Y, Manibusan A, Sellers AJ, Barnett RS, Srinagesh S, Forsyth JS, Hassenpflug W, Tian F, Javahishvili T, et al. A CXCR4-targeted site-specific antibody-drug conjugate. Angewandte Chemie (International Ed. in English). 53: 11863-7. PMID 25213874 DOI: 10.1002/Anie.201408103 |
0.543 |
|
2014 |
Wondimu A, Liu Y, Su Y, Bobb D, Ma JS, Chakrabarti L, Radoja S, Ladisch S. Gangliosides drive the tumor infiltration and function of myeloid-derived suppressor cells. Cancer Research. 74: 5449-57. PMID 25115301 DOI: 10.1158/0008-5472.Can-14-0927 |
0.311 |
|
2014 |
Lu H, Zhou Q, Deshmukh V, Phull H, Ma J, Tardif V, Naik RR, Bouvard C, Zhang Y, Choi S, Lawson BR, Zhu S, Kim CH, Schultz PG. Targeting human C-type lectin-like molecule-1 (CLL1) with a bispecific antibody for immunotherapy of acute myeloid leukemia. Angewandte Chemie (International Ed. in English). 53: 9841-5. PMID 25056598 DOI: 10.1002/Anie.201405353 |
0.589 |
|
2012 |
Lee HC, Wondimu A, Liu Y, Ma JS, Radoja S, Ladisch S. Ganglioside inhibition of CD8+ T cell cytotoxicity: interference with lytic granule trafficking and exocytosis. Journal of Immunology (Baltimore, Md. : 1950). 189: 3521-7. PMID 22956583 DOI: 10.4049/Jimmunol.1201256 |
0.524 |
|
2012 |
Vazquez-Cintron EJ, Monu NR, Burns JC, Blum R, Chen G, Lopez P, Ma J, Radoja S, Frey AB. Protocadherin-18 is a novel differentiation marker and an inhibitory signaling receptor for CD8+ effector memory T cells. Plos One. 7: e36101. PMID 22567129 DOI: 10.1371/Journal.Pone.0036101 |
0.395 |
|
2007 |
Ma JS, Monu N, Shen DT, Mecklenbräuker I, Radoja N, Haydar TF, Leitges M, Frey AB, Vukmanovic S, Radoja S. Protein kinase Cdelta regulates antigen receptor-induced lytic granule polarization in mouse CD8+ CTL. Journal of Immunology (Baltimore, Md. : 1950). 178: 7814-21. PMID 17548619 DOI: 10.4049/Jimmunol.178.12.7814 |
0.464 |
|
2006 |
Shen DT, Ma JS, Mather J, Vukmanovic S, Radoja S. Activation of primary T lymphocytes results in lysosome development and polarized granule exocytosis in CD4+ and CD8+ subsets, whereas expression of lytic molecules confers cytotoxicity to CD8+ T cells. Journal of Leukocyte Biology. 80: 827-37. PMID 16891618 DOI: 10.1189/Jlb.0603298 |
0.526 |
|
Show low-probability matches. |